Keefe, Bruyette & Woods lowers Moelis target to $66
Keefe, Bruyette & Woods analyst Aidan Hall maintained Moelis with a Market Perform rating and lowered the price target to $66 from $69. This contrasts with UBS analyst Michael Brown, who downgraded the stock to Sell while raising the price target to $60 from $58.

*this image is generated using AI for illustrative purposes only.
Keefe, Bruyette & Woods analyst Aidan Hall maintained Moelis with a Market Perform rating and lowered the price target to $66, reducing the outlook from the previous $69. This adjustment follows a separate downgrade by UBS analyst Michael Brown, who shifted the stock from Neutral to Sell with a raised price target of $60, up from $58.
Rating and Price Action
The consensus among analysts shows a divergence in outlook for the stock. While Keefe, Bruyette & Woods retains a neutral stance, UBS has adopted a more bearish position despite a modest increase in its price target.
| Firm | Rating | Price Target | Previous Target |
|---|---|---|---|
| Keefe, Bruyette & Woods | Market Perform | $66 | $69 |
| UBS | Sell | $60 | $58 |
What factors are driving the divergence in analyst ratings between KBW and UBS?
How might Moelis's recent financial performance influence future analyst adjustments?
What impact could these downgrades have on investor sentiment toward Moelis?

























